SCHEMBL3422138

SCHEMBL3422138

CC(C)CC(NC(=O)C(N)CCC(N)=O)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.56
▸ DPP8 Q6V1X1 2/20 0.56
▸ DPP9 Q86TI2 2/20 0.56
▸ FOLH1 Q04609 7/20 0.51
▸ KMT2A Q03164 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ LAP3 P28838 3/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CTSD P07339 1/20 0.45
▸ BACE1 P56817 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ LTA4H P09960 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537149 1.00 DPP4 (0.56) DPP4DPP8DPP9FOLH1KMT2A
Leucine SCHEMBL14126315 0.96 DPP4 (0.52) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL31121653 0.94 DPP4 (0.51) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL29777822 0.94 DPP4 (0.51) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL30974319 0.93 BACE1 (0.53) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL29381184 0.93 DPP4 (0.50) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL30060796 0.93 DPP4 (0.52) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL31199055 0.92 BACE1 (0.55) DPP4DPP8DPP9FOLH1CTSD
SCHEMBL1674769 0.90 FOLH1 (0.50) DPP4DPP8DPP9FOLH1KMT2A
SCHEMBL28556186 0.89 DPP4 (0.58) DPP4DPP8DPP9FOLH1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106455664-A Composition with high content of cyclic dipeptide 三得利控股株式会社 2017-02-22 — — CN claimed
CN-106456633-A Sugar metabolism improving agent 三得利控股株式会社 2017-02-22 — — CN claimed
US-20230404951-A1 Pet Food Compositions HILL'S PET NUTRITION, INC. (US) 2023-12-21 — — US disclosed
US-20210069268-A1 METABOLOMIC REVISION OF MAMMALIAN INFANTS Evolve Biosystems, Inc. (US) 2021-03-11 — — US disclosed
EP-3681521-A1 METABOLOMIC REVISION OF MAMMALIAN INFANTS Evolve Biosystems Inc. (US) 2020-07-22 — — EP disclosed
WO-2019055718-A1 METABOLOMIC REVISION OF MAMMALIAN INFANTS Evolve Biosystems, Inc. (US) 2019-03-21 — — WO disclosed
CN-106455664-A Composition with high content of cyclic dipeptide 三得利控股株式会社 2017-02-22 — — CN disclosed
CN-106456633-A Sugar metabolism improving agent 三得利控股株式会社 2017-02-22 — — CN disclosed
WO-2010020825-A2 UROCORTIN 3 FRAGMENTS AND ANALOGS, THEIR PREPARATION AND USE AS ANTIDEPRESSIVE AND ANXIOLYTIC AGENTS Szegedi Tudományegyetem (HU) 2010-02-25 — — WO disclosed
US-20060217321-A1 Compositions to improve tic disorders TAIYOKAGAKU CO., LTD. (JP) 2006-09-28 — — US disclosed
Send feedback